US › Healthcare

XWELL Inc. (XWEL)

US · Healthcare · Diagnostics & Research

$0.91-0.55%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$7.1M

Revenue YoY

-7.1%

Net profit

$-2.2M

EPS

$-0.26

Net margin

-31.3%

Key statistics

Market cap

$8.3M

Forward P/E

10.8

P/B

20.33

Book value

$0.05

EPS (TTM)

$-5.21

52-week high

$2.20

52-week low

$0.26

50-day MA

$1.00

200-day MA

$0.98

Beta

1.00

Analyst view

Analysts rate XWELL Inc. a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $7.00.

Shareholding

Insiders

27.11%

Institutions

16.83%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	1.36%
Sontag Advisory LLC	1.22%
Jane Street Group LLC	0.96%
BlackRock Inc	0.95%
Geode Capital Management, LLC	0.79%
Vanguard Capital Management, LLC	0.60%
Vanguard Fiduciary Trust Co	0.27%
Morgan Stanley - Brokerage Accounts	0.25%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for XWELL Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.